AVXL - ANAVEX LIFE SCIENCES CORP.

QQQ $ 629.78 $ -3.11 (-0.49 %)

DIA $ 472.70 $ -2.66 (-0.56 %)

SPY $ 681.88 $ -2.29 (-0.33 %)

TLT $ 89.68 $ 0.07 (0.08 %)

GLD $ 366.72 $ 0.05 (0.01 %)

Previous Close

$ 7.74

Open

$ 7.90

Bid

$ 7.45 x 29

Ask

$ 8.41 x 10

Day's Range

$ 7.45 - $ 7.94

52 Week Range

$ 6.62 - $ 14.44

Volume

1,657,000

Average Volume

Market Cap

664.82M

Beta (5Y Monthly)

$ 1.58

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	02-12-2025	12-31-2024	10-Q
4	12-23-2024	09-30-2024	10-K
5	08-06-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-07-2024	12-31-2023	10-Q
8	11-27-2023	09-30-2023	10-K
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	02-07-2023	12-31-2022	10-Q
12	11-28-2022	09-30-2022	10-K
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	02-09-2022	12-31-2021	10-Q
16	11-24-2021	09-30-2021	10-K
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	02-16-2021	12-31-2020	10-Q
20	12-28-2020	09-30-2020	10-K
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-06-2020	12-31-2019	10-Q
24	12-16-2019	09-30-2019	10-K
25	08-07-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	02-07-2019	12-31-2018	10-Q
28	12-12-2018	09-30-2018	10-K
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	02-07-2018	12-31-2017	10-Q
32	12-11-2017	09-30-2017	10-K
33	08-07-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	02-07-2017	12-31-2016	10-Q
36	12-14-2016	09-30-2016	10-K
37	08-11-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	02-08-2016	12-31-2015	10-Q
40	12-29-2015	09-30-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

D. Boral Capital Maintains Buy on Anavex L...
10/29/2025 12:43:48

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

anavex-life-sciences-alzheimers-drug-candidate-shows-continued-long-term-benefit-versus-control-group

Anavex Life Sciences' Alzheimer's Drug Can...
10/29/2025 11:31:58

Anavex reports sustained cognitive benefits from oral blarcamesine, showing slower Alzheimer's progression and long-term ef...

Anavex Life Sciences' Alzheimer's Drug Can...
10/29/2025 11:31:53

Anavex reports sustained cognitive benefits from oral blarcamesine, showing slower Alzheimer's progression and long-term ef...

Anavex Life Sciences Says '77.4 Weeks (17....
10/29/2025 11:30:03

Anavex Life Sciences Says 'ADAS-Cog13 diff...
10/29/2025 11:29:55

Anavex Life Sciences Says Co. Announces Co...
10/29/2025 11:29:47

Jones Trading Downgrades Anavex Life Scien...
10/24/2025 12:14:04

Jones Trading analyst Soumit Roy downgrades Anavex Life Sciences (NASDAQ:AVXL) from Buy to Hold.

Anavex Highlights Oral Blarcamesine's Pati...
10/10/2025 11:31:42

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

HC Wainwright & Co. Reiterates Buy on Anav...
10/07/2025 10:47:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

D. Boral Capital Maintains Buy on Anavex L...
10/02/2025 14:37:19

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Announces Development...
10/02/2025 11:37:18

ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adultsOral ANA...

Anavex Schizophrenia Drug Shows Safety Res...
10/02/2025 11:32:24

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

D. Boral Capital Maintains Buy on Anavex L...
10/01/2025 11:27:26

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Announces Publication...
09/30/2025 12:31:28

HC Wainwright & Co. Reiterates Buy on Anav...
09/10/2025 16:45:29

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

D. Boral Capital Maintains Buy on Anavex L...
09/10/2025 11:31:09

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Highlights New Clinic...
09/09/2025 11:36:57

New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer&#...

D. Boral Capital Maintains Buy on Anavex L...
08/27/2025 12:08:08

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Publishes iScience Study Confirming...
08/26/2025 11:41:34

HC Wainwright & Co. Reiterates Buy on Anav...
08/22/2025 10:43:22

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...